Regensburg, Germany; Istanbul, Turkey, May 28th 2024 –<\/p>\n
lifespin GmbH, a pioneer in health status detection software, has teamed up with Ac\u0131badem University (ACU) and Ac\u0131badem Healthcare Group (AHG) to launch a comprehensive precision medicine initiative, a significant stride towards revolutionizing personalized healthcare. This collaboration is set to develop and expand the global market for innovative healthcare solutions that utilize a combination of advanced Nuclear Magnetic Resonance (NMR) and AI technologies. Under the agreement, lifespin GmbH and ACU will combine their expertise to establish a state-of-the-art, AI-enabled, NMR-based metabolomics precision medicine platform. This joint venture will focus on deploying lifespin\u2019s cutting\u0002edge products across ACU\u2019s extensive network through a Software as a Service (SaaS) model, offering these technologies at competitive rates<\/p>\n
The partnership\u2019s mission extends beyond improving patient care across Eurasia; it ambitiously targets expansion into Africa and the Arabian Peninsula, with Istanbul positioned as the central hub. Moreover, this strategic alignment promises to bridge continents with top-tier healthcare solutions, enhancing access to advanced healthcare diagnostics. \u201cWe are thrilled to collaborate with Ac\u0131badem University to push the boundaries of AI-based precision medicine tools in the healthcare provider sector,\u201d said Dr. Ali Tinazli, CEO of lifespin GmbH. \u201cOur combined efforts will not only advance medical technology but also make these tools for personalized medicine more accessible.\u201d<\/p>\n
Prof. Dr. Ahmet \u015eahin, representative of Ac\u0131badem University, \u201cThis partnership stands as a testament to our commitment to healthcare innovation. We aim to transform the landscape of medicine, making personalized healthcare a reality for millions.\u201d In addition to commercial endeavors, lifespin and Ac\u0131badem University are eager to explore opportunities for joint development of new healthcare solutions as well as the digitalization of ACU\u2019s extensive biobank. The agreement also encompasses the creation of a Regional Data Analysis and Data Production Center Laboratory, which will support the development and distribution of lifespin\u2019s products globally<\/p>\n
About lifespin GmbH<\/strong><\/p>\n lifespin GmbH is developing affordable, omni-intelligent health status assessment software enabled by its proprietary AI algorithms. Leveraging a proprietary combination of NMR and advanced algorithms as cloud-based SaaS business, lifespin is dedicated to enhancing personalized healthcare solutions globally. Lifespin has built one of the largest and most comprehensive databases of metabolomic health profiles across 240,000+ healthy and diseased individuals covering multiple age and biological sex groups as well as specific diseases in neurology, oncology, and inflammation. Lifespin\u2019s advisory board consists of key opinion leaders such as James Rothman (Nobel Laureate in Physiology\/Medicine, Sterling Professor of Cell Biology, Yale University, New Haven, CT USA) and other prominent leaders in the relevant fields of study<\/p>\n About Acibadem<\/strong><\/p>\n Ac\u0131badem Healthcare Group was established in 1991, rapidly becoming one of the leading institutions in Turkey within the field of private healthcare services. In 2012 the company partnered with IHH Healthcare. This move made Ac\u0131badem part of the world\u2019s second largest healthcare chain with its 24 hospitals and 15 outpatient clinics, as well as 7 cancer centers. All centers are nationally and internationally accredited and qualified. Ac\u0131badem University is renowned for its contribution to healthcare education and research, fostering innovation and excellence in medicine through cutting-edge technologies and comprehensive healthcare services.<\/p>\n